Daniel Kim

[Cedars-Sinai Internal Medicine Residency @CSIMResidents]

Cedars residents kicking off another day at #ISHLT2023 with a presentation by star second year Manvir!

[Eric K. Kim @EKKimMD]

A dream come true! Thank you to everyone who has supported me and kept me strong on this journey. Excited to ~stay forever~ @UCSF_OHNS
#Match2023 #iamoto #otomatch

[Brandon Yan, MD MPH @BYan415]

Thrilled to match at @UCSF @UCSFIMChiefs for #InternalMedicine!!! A dream come true to continue training & serving in the city that raised me.

This is to the family, friends, mentors, and patients I've been privileged to have on this journey. We did it!!
#Match2023

[UCSF GS Residency @UCSFGSResidency]

We are incredibly thrilled to introduce our new General Surgery categorical resident class of 2030! Big congratulations are in order – we are SO excited to welcome you to @UCSFSurgery this June and see you begin your journeys to becoming leaders in surgery! 🎉🎉🎉

[USC Otolaryngology @uscohns]

Congratulations to our new residents! #USCOHNS clinical residency program welcomes three interns: Joseph Kidane, Daniel Palmieri, and Andrew Woodhouse, while Kevin Biju will join as the resident of our Clinician Scientist Training Program.
#KSOMMatch2023 #OTOMatch #MatchDay

[Miguel Nuñez @MiNunez95]

That’s my roomate! Congrats @LuisRCarrete

[Daniel Kim @danielkimdk]

@MiNunez95 Fantastic present to yourself. Enjoy!

[Daniel Kim @danielkimdk]

The most clever of titles. Hats off to the wonderful Dr. @kongalan96 and his paper on glaucoma. Coming to a high school reading list near you.

[Alan Kong @kongalan96]

The Catcher in the Eye? It's not a JD Salinger typo! Check out one of my last papers from @UCSFMedicine entitled, The Catcher in the Eye: Stem Cells as a Therapeutic for Glaucoma. @AAOjournal #UCSFOphthalmology https://t.co/N6FV3PYEew

[Daniel Kim @danielkimdk]

Learned a new word today: “migraineurs.” Fantastic article published by the amazing @erickidongkim. That’s an ENT doctor in the making!

[Eric K. Kim @EKKimMD]

Migraineurs have an earlier age of BPPV onset than those without migraine.

https://t.co/b2Av7cjOrq

[Daniel Kim @danielkimdk]

@erickidongkim @UCSF_OHNS Congrats eric! Incredible work and sounds like you have an amazing mentor.

[Daniel Kim @danielkimdk]

So proud!! Congrats @BYan415 🤩

[Brandon Yan, MD MPH @BYan415]

Honored that Medical Care Research & Review editors chose our study on the concurrent effects of #ACA #MedicaidExpansion & #opioid epidemic on mortality as Article of the Year 2021! Thank you.

Team effort w/ @RAdamsDudleyMD FrankSloan at @UCSF_IHPS @DukeSanford @DukeEcon #ARM22

[Daniel Kim @danielkimdk]

@Gochmed @KidaneMD @UCSF_OHNS @Triological @__COSM @KidaneMD 👏 👏 👏 so amazing!!

[Daniel Kim @danielkimdk]

@resiDrWright @UCSF_GCP @UCSF 👏👏👏 the Wright sibling powerhouse

[Daniel Kim @danielkimdk]

One of many awards this guy will get. Congrats to my roommate and future transplant surgeon!

[UCSF Surgery @UCSFSurgery]

👨🏻‍⚕️Mr. Miguel Nunez @MiNunez95 took home the award for Best Medical Student Presentation✨for his findings on "Preclinical testing of AAV capsid transduction efficiency and specificity in ex vivo perfused human liver"👏👏👏

[Jojo Kidane, MD @kidanemd]

If you are a singer (at any level!) please help my team at the UCSF Voice and Swallowing Center by filling out this survey. https://t.co/4akfOtltDs

[Daniel Kim @danielkimdk]

@erickidongkim Sounds like a great break!

[Daniel Kim @danielkimdk]

An absolute blast! Thanks to the team today who got me through that case.

[Anand Patel @Anand_88_Patel]

Wow, what a case from @ecvasti for @CPSolvers VMR! Pleasure to discuss with @SZKamal @lbphin
@danielkimdk and awesome summary of the case & teaching by @pri_athavale @AndreaAnampaG, here's a resource about neuro complications in liver tx:
https://t.co/HxIeGoFj6L

[Daniel Kim @danielkimdk]

Overall survival at 12 months at 67.2% (atezo+beva) vs 54.6% (#sorafenib) for #livercancer--the first therapy to improve survival since FDA approval of sorafenib 12 years ago. Enough for the important people in life to attend a graduation, a wedding, their first grandchild.

[HUNTER: Hepatocellular Carcinoma Expediter Network @HCC_HUNTER]

A very exciting study was just published in @NEJM showing that in patients with unresectable #HCC, a new treatment combination (#atezolizumab+#bevacizumab) resulted in better overall and progression-free survival than the current treatment #sorafenib! https://t.co/LwJA0RFnCf

[Francis Wright, MD @DrFrankWright]

Had a great time learning from this all star team of students and doctors @danielkimdk @ejphilip Led by Vadim Koshkin MD @koshkin85